BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34108675)

  • 1. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
    Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
    Bone Marrow Transplant; 2021 Oct; 56(10):2471-2476. PubMed ID: 34108675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
    Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
    Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
    Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
    Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
    J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
    Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
    Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Kilic Gunes E; Yigit Kaya S; Yaman F; Yeniay MK; Vural K; Comert M; Sevindik OG; Andic N; Dagdas S; Nizam Ozen I; Kaynar L; Yavasoglu F; Ozet G; Karakus V; Ayli M
    Leuk Res; 2024 May; 140():107484. PubMed ID: 38520796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia.
    Bostankolu Değirmenci B; Yegin ZA; Dikyar A; Aydın Kaynar L; Özkurt ZN; Uyar Göçün P; Akyürek N
    Leuk Res; 2022 Jul; 118():106870. PubMed ID: 35665626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.
    Uria-Oficialdegui ML; Alonso L; Benitez-Carabante MI; Renedo B; Oliveras M; Diaz-de-Heredia C
    Pediatr Transplant; 2021 Jun; 25(4):e14010. PubMed ID: 33742757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
    Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eltrombopag for thrombocytopenia in 24 children after hematopoietic stem cell transplantation].
    Liu S; Que LP; Huang K; Fang JP; Wang KM; Zhan LP; Liu DD; Xu HG
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):311-315. PubMed ID: 33775051
    [No Abstract]   [Full Text] [Related]  

  • 11. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
    Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
    Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
    Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients.
    Ahn HJ; Byun JM; Kim I; Youk J; Koh Y; Shin DY; Hong J; Yoon SS
    J Korean Med Sci; 2022 Feb; 37(6):e48. PubMed ID: 35166084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
    Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
    Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia.
    Gao F; Zhou X; Shi J; Luo Y; Tan Y; Fu H; Lai X; Yu J; Huang H; Zhao Y
    Ann Hematol; 2020 Nov; 99(11):2679-2687. PubMed ID: 32519094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
    Qiu KY; Liao XY; Huang K; Wu RH; Xu HG; Xu LH; Li Y; Weng WJ; Zhou DH; Fang JP
    Br J Clin Pharmacol; 2021 Apr; 87(4):2023-2031. PubMed ID: 33080064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
    Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Eltrombopag in Thrombocytopenia Post Hematopoietic Cell Transplantation: Rertrospective Observational Trial.
    Samarkandi H; Al Nahedh M; Alfattani A; Alsharif F; Bakshi N; Rasheed W; Alfraih F; Alhumaid M; Alkhudair N; Alhayli S; Alsaedi H; Shaheen M; Hanbali A; Hashmi SK; Devol E; Alseraihy A; Alzahrani H; Aljurf M
    Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):285-290. PubMed ID: 32755559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function.
    Arslan Davulcu E; Akad Soyer N; Vural F
    Cureus; 2023 Sep; 15(9):e44555. PubMed ID: 37790070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children.
    Li S; Wu R; Wang B; Fu L; Zhu G; Zhou X; Ma J; Zhang L; Qin M
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):38-41. PubMed ID: 30080752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.